Acusphere's Imagify to get FDA review

AuntMinnie.com staff writers

Oct 12, 2008

Ultrasound contrast developer Acusphere said that its Imagify contrast agent will be reviewed during a planned public meeting of the U.S. Food and Drug Administration (FDA)'s Cardiovascular and Renal Drugs Advisory Committee on December 10.

Imagify has a proposed indication for patients with stable chest pain being evaluated for inducible ischemia for the detection of coronary artery disease based on assessment of myocardial perfusion and wall motion, according to the Watertown, MA-based firm.

Related Reading

Acusphere taps new VP, September 25, 2008

Acusphere receives Nasdaq noncompliance notice, August 14, 2008

Acusphere reports Q2 results, August 12, 2008

Acusphere cuts staff, July 29, 2008

Acusphere gets Nasdaq warning letter, July 15, 2008

Copyright © 2008 AuntMinnie.com

Screenshot (1142)

POCUS used widely in lung ultrasound applications

April 17, 2024

UltraCon: Expert talks ultrasound's role in imaging dense breasts

April 12, 2024

Andreas Giannakou, MD, from Brigham & Women’s Hospital and Harvard Medical School presents research highlighting how many women with early-stage HR+HER2- breast cancer and a negative presurgical axillary ultrasound can skip sentinel lymph node biopsy.

Negative axillary ultrasound can lead to breast biopsy omission

April 12, 2024

Jennifer Bagley from the University of Oklahoma Health Sciences Center presents results at UltraCon suggesting that work-related musculoskeletal disorders are tied to burnout among sonographers.

UltraCon: Work-related MSK disorders tied to sonographer burnout

April 11, 2024

POCUS used widely in lung ultrasound applications

By Amerigo Allegretto

Some of the top domains for users of point-of-care ultrasound (POCUS) incorporate the technology for lung ultrasound applications.

April 17, 2024

Screenshot (1142)

UltraCon: Expert talks ultrasound's role in imaging dense breasts

By Amerigo Allegretto

Kibo Nam, PhD, from Thomas Jefferson University spoke with AuntMinnie.com about the current state of ultrasound in imaging dense breasts.

April 12, 2024

Negative axillary ultrasound can lead to breast biopsy omission

By Amerigo Allegretto

Many women with early-stage HR+HER2- breast cancer and a negative presurgical axillary ultrasound can skip sentinel lymph node biopsy.

April 12, 2024

Andreas Giannakou, MD, from Brigham & Women’s Hospital and Harvard Medical School presents research highlighting how many women with early-stage HR+HER2- breast cancer and a negative presurgical axillary ultrasound can skip sentinel lymph node biopsy.

UltraCon: Work-related MSK disorders tied to sonographer burnout

By Amerigo Allegretto

Work-related musculoskeletal (MSK) disorders are tied to work-related burnout among sonographers, according to research highlighted April 10 at UltraCon.

April 11, 2024

Jennifer Bagley from the University of Oklahoma Health Sciences Center presents results at UltraCon suggesting that work-related musculoskeletal disorders are tied to burnout among sonographers.

CEUS adds to locoregional therapy for liver disease

By Amerigo Allegretto

Contrast-enhanced ultrasound (CEUS) can improve locoregional therapy for treating metastatic disease of the liver.

April 11, 2024

Corinne Wessner from Thomas Jefferson University discusses early study results at UltraCon showing the potential of ultrasound-triggered microbubble destruction in treating liver disease.

UltraCon: Harmonic motion imaging tracks breast tumor response to chemo

By Amerigo Allegretto

Harmonic motion imaging can track mechanical property changes of breast tumors in response to neoadjuvant chemotherapy.

April 10, 2024

Yangpei Liu from Columbia University in Ney York City discussed findings at UltraCon suggesting that harmonic motion imaging could be a viable predictor of early treatment response.

UltraCon: Former Medtronic CEO talks ultrasound's future with AuntMinnie.com

By Amerigo Allegretto

Former Medtronic Chairman and CEO Omar Ishrak, PhD, spoke with AuntMinnie.com at UltraCon on the future of ultrasound and market creation.

April 10, 2024

UltraCon: Machine learning predicts sonographer burnout

By Amerigo Allegretto

Machine-learning approaches can predict burnout among sonographers, though established burnout indices may be enough, according to research presented April 9 at UltraCon.

April 9, 2024

Jennifer Bagley from the University of Oklahoma presents findings at UltraCon on the performance of two machine learning approaches in predicting burnout among sonographers.

UltraCon: Ultrasound empowers patients with prosthetic limbs

By Amerigo Allegretto

Gil Weinberg, PhD, a founding director of Georgia Tech's Center for Music Technology, spoke with AuntMinnie.com on ultrasound's use in prosthetics.

April 9, 2024

SRU releases consensus statement on endometriosis detection

By Amerigo Allegretto

The Society of Radiologists in Ultrasound (SRU) has issued a new expert consensus statement that aims to improve endometriosis evaluation.

April 9, 2024

Screenshot (1140)

UltraCon: Microflow imaging on par with CEUS for guiding tumor ablation

By Amerigo Allegretto

Microflow imaging performs just as well as contrast-enhanced ultrasound (CEUS) for guiding tumor ablation and may be an economic alternative.

April 9, 2024

Ziyue Hu, MD, from Sichuan Cancer Hospital in China highlighted findings at UltraCon, showing that along with comparable performance in treating thyroid nodules, microflow imaging is a less costly and invasive approach to tumor ablation than CEUS.

UltraCon: Can standardized training improve eFAST learning?

By Amerigo Allegretto

A standardized training curricula can be well-received by emergency faculty who are learning extended focused assessment with sonography in trauma (eFAST).

April 8, 2024

Jacqueline Gomberg, MD, from NYU Langone Health/Bellevue in New York discusses her team's faculty training course for extended focused assessment with sonography in trauma (eFAST).

Page 1 of 509